The Beacon Installed on the B-SCREEN Platform at IHU Méditerranée Infection
Accelerating innovation in infectious diseases requires strong links between patient samples, advanced research and therapeutic development.
Marseille, March 9, 2026 –Following more than six months of collaborative work, Beacon™ technology has now been installed on the B-SCREEN platform at IHU Méditerranée Infection in Marseille. This marks an important step in establishing a long-term collaboration between Marseille Immunology Biocluster (MIB) and the IHU, supporting an integrated and translational approach to immunology.
A platform supporting therapeutic antibody discovery
The B-SCREEN platform plays a key role in accelerating scientific innovation. It enables the identification and characterisation of monoclonal antibodies with significant clinical potential from patient samples.
Through the high-throughput screening capabilities of Beacon™ technology, researchers can conduct detailed analyses of B- and T-cell immune repertoires and rapidly identify cells producing antibodies of interest.
This approach draws on a range of complementary tools that enable:
In-depth analysis of B-cell receptor (BCR) and T-cell receptor (TCR) repertoires;
Precise characterisation of immune cell subpopulations;
Antibody cloning and production;
Comprehensive functional assays, including specificity, affinity, ligand blocking and cellular functions.
Bridging the gap between discovery and clinical application
By combining these advanced technological capabilities, B-SCREEN helps bridge the gap between scientific discovery and therapeutic innovation.
While the platform directly supports infectious disease research, its applications also extend to other major areas of immunology, including:
Autoimmune diseases;
Inflammatory diseases;
Immuno-oncology.
This approach is fully aligned with Marseille Immunology Biocluster’s strategy to accelerate the discovery and development of new immunotherapies by connecting fundamental research, clinical research and industrial innovation.
A collaboration supporting Marseille's scientific ecosystem
The installation of Beacon technology on the B-SCREEN platform illustrates the ongoing collaboration between scientific organisations in the region.
By bringing together technological infrastructure, clinical resources and expertise in immunology, this initiative strengthens the capacity of Marseille’s scientific ecosystem to translate research discoveries into tangible therapeutic innovations for the benefit of patients.
Actualités